Pamela Stephenson - Mar 28, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Mar 28, 2022
Transactions value $
-$13,858
Form type
4
Date filed
3/29/2022, 04:00 PM
Previous filing
Jan 25, 2022
Next filing
Apr 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$13.9K -454 -0.97% $30.53 46.3K Mar 28, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 14,344 shares of common stock and 31,975 restricted stock units.